FINWIRES · TerminalLIVE
FINWIRES

BriaCell Therapeutics Inks MOU With Dutch Microneedle Company

By

BriaCell Therapeutics (BCT.TO) has signed a memorandum of understanding (MOU) with a Dutch microneedle company whose device is already being used in its Phase 3 study in advanced metastatic breast cancer.

The MOU aims to establish a plan for scaling up of Uneedle's microneedle devices for use in commercial quantities. This is dependent on BriaCell's lead Phase 3 clinical candidate, Bria-IMT, obtaining regulatory approval.

Bria-IMT, an immunotherapy candidate, is currently being evaluated in a Phase 3 study in advanced metastatic breast cancer. Uneedle's microneedle technology is being used to intradermally administer Bria-IMT, a statement said.

Related Articles

Mining & Metals

Blue Moon Metals Reports Major Development Milestones at Its Nussir Project in Norway

Blue Moon Metals (MOON.V, BMM) after trade Wednesday detailed several milestones for its Nussir copper-silver-gold project in Norway.The company said it awarded the engineering, procurement, and construction contract to MOMEK Services AS for the project's processing plant. It added that the award aligns with its execution plan set out in the April feasibility study on the project and furthers the project towards full-scale construction and production in the fourth quarter of 2027.In addition, the Norwegian Environment Agency approved the project's Waste Management Plan and updated discharge permit. The Norwegian Directorate of Mines also approved the project's revised mine operating plan, according to the statement."With our permitting framework now complete, our long-lead equipment on order, our mine decline advancing to the orebody, and our key construction contracts in place, we are on track to deliver production later in 2027," Chief Executive Christian Kargl-Simard said.The company's shares closed down C$0.57 to C$7.88 on the TSX Venture Exchange.

$BMM$MOON.V
Mining & Metals

Evertz Technologies Reports Higher Profit, Revenue for Fiscal Fourth Quarter

Evertz Technologies (ET.TO) after trade Wednesday said its fiscal fourth-quarter profit and revenue rose year-over-year.The video and audio technologies company earned C$15.3 million, or C$0.20 per diluted share, in the period, up from C$13 million, or C$0.17, a year ago. FactSet expected C$0.19 per share.Revenue rose 3% for the quarter ended April 30 to C$131.6 million from C$127.8 million a year prior. FactSet projected C$130.7 million.For the quarter, revenue in the US. and Canada was C$94.2 million, down from C$106.5 million a year ago. Revenue in the International region was C$37.4 million, up C$16.1 million from C$21.3 million in the same quarter last year, the company said.The board declared a regular quarterly dividend of C$0.205 per share, payable to shareholders of record on July 6 and will be paid on or about July 13.The company's share closed up C$0.28 to C$16.52 on the Toronto Stock Exchange.

$ET.TO
Mining & Metals

Timbercreek Financial Declares June Dividend of C$0.0575

Timbercreek Financial (TF.TO) on Wednesday declared a monthly cash dividend of $0.0575 per share, unchanged from the prior month, it said on Wednesday.The dividend will be paid on July 15 to shareholders of record on June 30.Price: $6.59, Change: $+0.01, Percent Change: +0.15%

$TF.TO